U.S. federal trademark · Serial No. 50017135
Custom manufacture of biopharmaceuticals; Custom manufacture of viral vectors and viral vector-based pharmaceutical products for use in gene therapy, cell therapy, and advanced therapy medicinal products; Custom manufacture of viral vectors, cell banks, viral banks, related biological materials, and pharmaceutical products for use in preclinical, clinical, and commercial gene therapy, cell therapy, vaccines, and oncolytic viral therapies; Manufacturing services for others in the field of viral vectors, cell banks, viral banks, related biological materials, and pharmaceutical products for use in preclinical, clinical, and commercial gene therapy, cell therapy, vaccines, and oncolytic viral therapies
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceuticals for cell and gene therapies; Testing of pharmaceuticals for cell and gene therapies; Laboratory services for producing viral vectors for pharmaceutical use; Laboratory services for biomanufacturing viral vectors for pharmaceutical use; Laboratory services for biomanufacturing vaccines, oncolytic viral therapies, and advanced therapy medicinal products; Laboratory services for the production of pharmaceuticals in the nature of developing, testing, and characterizing cell banks and viral banks; Scientific and technological services, namely, development of assays, cell lines, cell banks, viral banks, analytical testing, processes, product characterization, and manufacturing, quality, and regulatory testing in the field of viral vectors, gene therapy, cell therapy, vaccines, oncolytic viral therapies, and advanced therapy medicinal products; Technological planning and consulting services in the field of viral vector development and manufacturing
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.